Search
Now showing items 1-1 of 1
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
Döhner, Hartmut et al. (2014)
Wissenschaftlicher Artikel
Now showing items 1-1 of 1